Dr Shalini Singh

2. Name: Dr Shalini Singh

3. Designation:  

4. Qualifications :  

5. Email ID :- This email address is being protected from spambots. You need JavaScript enabled to view it.

6. Field of Interest

Consultation Liaison Addiction Psychiatry

Management of alcohol dependence in those with alcohol related liver disease

Safe use of opioids for management of chronic non-cancer pain

Viral hepatitis in those who inject drugs: improved screening protocols

Prevention of substance use disorders

Student wellness

Training of healthcare professionals in management of substance use disorders

7. Total number of publications till date: >40

8. Details of publications since 2010 onwards (the full citation)- these should be divided into journal  articles (peer reviewed publications) and books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

Journal articles:

1. Balhara YPS, Sarkar S, Singh S. Medical Use, Decriminalization, and Legalization of Narcotic Drugs and Psychotropic Substances—What Does It Mean and What Is Its Current Status in India? Indian Journal of Psychological Medicine. 2022;0(0). doi:10.1177/02537176221138496

2. Jaiswal P, Mahey R, Singh S, Vanamail P, Gupta M, Cheluvaraju R, Sharma JB, Bhatla N. Psychological impact of suspension/postponement of fertility treatments on infertile women waiting during COVID pandemic. Obstet Gynecol Sci. 2022 Mar;65(2):197-206. doi: 10.5468/ogs.21254. Epub 2022 Jan 20. PMID: 35045244; PMCID: PMC8942756.

3. Singh S, Dhawan A. Problematic substance and internet use among medical students. Indian J Soc Psychiatry 2021;37:172-7

4. Choudhary N, Singh S, Rathore P, Ambekar A, Bhatnagar S. Opioid Use Disorders among Patients on Long-Term Morphine for Management of Chronic Cancer Pain: A Pilot Study from a Tertiary Palliative Care Facility. Indian J Palliat Care. 2021 Apr-Jun;27(2):264-268. doi: 10.25259/IJPC_358_20. Epub 2021 Aug 12. PMID: 34511794; PMCID: PMC8428893.

5. Bhatnagar S, Kumar S, Rathore P, Sarma R, Malhotra RK, Choudhary N, Thankachan A, Haokip N, Singh S, Pandit A, Vig S, Ratre BK, Mohan A, Lorenz K, Guleria R. Surviving COVID-19 is Half the Battle; Living Life with Perceived Stigma is Other Half: A Cross-Sectional Study. Indian J Psychol Med. 2021 Sep;43(5):428-435. doi: 10.1177/02537176211029331. Epub 2021 Aug 11. PMID: 34584309; PMCID: PMC8450733.

6. Tripathi R, Singh S, Sarkar S, Lal R, Balhara YP. Pathway to care in co-occurring disorder and substance use disorder: an exploratory, cross-sectional study from India. Advances in Dual Diagnosis. 2021 Feb 8.

7. Tripathi R, Singh S, Bhad R. The need, scope, challenges, and potential solutions for enhancing addiction psychiatry training in India. Indian Journal of Psychiatry. 2020 Nov 1;62(6):728.

8. Dhagudu NK, Ambekar A, Agrawal A, Rao R, Mishra AK, Jain R, Singh S. Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double-blind, within-subject, crossover study among opioid-dependent subjects. Drug Alcohol Rev. 2020 Jul;39(5):595-603. doi: 10.1111/dar.13057. Epub 2020 Mar 11. PMID: 32162420.

9. Balhara YPS, Singh S, Kalra S. Pragmatic Opioid Use in Painful Diabetic Neuropathy. Eur Endocrinol. 2020 Apr;16(1):21-24. doi: 10.17925/EE.2020.16.1.21. Epub 2020 Feb 4. PMID: 32595765; PMCID: PMC7308105.

10. YPS Balhara, Harshwardhan M, Kumar R, Shalini Singh. “Extent and pattern of problematic internet use among school students from Delhi: Findings from the cyber awareness programme,” Asian Journal of Psychiatry (2020),

11. Rao R, Varshney M, Singh S, Agrawal A, Ambekar A. Mental Healthcare Act, 2017, and addiction treatment: Potential pitfalls and trepidations. Indian J Psychiatry. 2019 Mar-Apr;61(2):208-212. doi: 10.4103/psychiatry.IndianJPsychiatry_463_18. PMID: 30992618; PMCID: PMC6425793.

12. Balhara YPS, Singh S, Sarkar S. Are the Patients Ready for the Change?: An Empirical Study to Evaluate the Impact of Change in Formulation of Buprenorphine-Naloxone on Prescription Pattern, Treatment Adherence, and Patient Satisfaction. Subst Use Misuse. 2019;54(2):307-314. doi: 10.1080/10826084.2018.1517799. Epub 2018 Dec 4. PMID: 30513249.

13. Nandan Choudhary, Sushma Bhatnagar, Atul Ambekar, and Shalini Singh. “A cross-sectional study to measure rate of opioid use disorder in patients on long-term opioid analgesic therapy for management of chronic cancer pain. Oral Presentation Abstracts.” Indian Journal of Palliative Care 24, no. 2 (2018): 207–27. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915891/.

14. Shalini Singh, Rakesh Lal, Dinu Chandran, KK Deepak. “Reduced heart rate variability in alcohol use disorder: relationship with severity of depressive symptoms in post acute alcohol withdrawal state : Young Psychiatrist Award, Indian Journal of Psychiatry 60, Supplement 1 ( Febuary, 2018): 2

15. Shalini Singh, Sonali Jhanjee, Deepak Yadav. “Illness narratives of female substance user from an Indian Urban slum a clinical and social perspective on presentation and rehabilitation "College of Problems on Drug Dependence Annual Meeting Abstract Book ( 2017) pg. 325

16. Shalini Singh. “Illness Narratives of Substance Users from Urban India: The Untold Stories of Their ‘Afflictions.’” Medicine Anthropology Theory | An Open-Access Journal in the Anthropology of Health, Illness, and Medicine 4, no. 3 (September 28, 2017): 173.

17. Shalini Singh, Ganesh Kumar Mallaram, and Siddharth Sarkar. “Pathological Gambling: An Overview.” Medical Journal of Dr. D.Y. Patil University 10, no. 2 (March 1, 2017): 120. https://doi.org/10.4103/0975-2870.202105.

18. Shalini Singh, and Yatan Pal Singh Balhara. “A Review of Indian Research on Co- Occurring Cannabis use Disorders & psychiatryc Disorders " Indian Journal of Medical Research 146 no. 2( Feb.1, 2017) 186  https://doi.org/10.4103/ijmr.IJMR_791_15.

20. Shalini Singh & Siddharth Sarkar. “Benzodiazepine abuse among the elderly.” Journal of Geriatric Mental Health [serial online] 2016 [cited 2017 Mar 10]; 3:123-30. DOI: 10.4103/2348-9995.195605

21. Tamonud Modak, YPS Balhara, Shalini Singh. ”Correlation Between Severity of  Alcohol Use Disorder & Disability Among Persons Seeking Treatment at a Tertiary care Drug Dependence Treatment Center Free paapers " Indian Journal of Psychiatry 58, no. 5 ( Jan.1, 2016): 41

22. YPS Balhara, Tamunod Modak, Shalini Singh. “Can IDEAS be used to assess disability among individuals with alcohol use disorder?: Findings from a cross-sectional observational study Free papers.” Indian Journal of Social Psychiatry 32, no. 4 (2016):

23. YPS Balhara, Shalini Singh, Modak T, Sarkar S. “A cross- sectional study to assess disability and its correlates among treatment seeking individuals with alcohol use disorders.” Indian Journal of Psychological Medicine 39 (2017): 40-5.

24. Yatan Pal Singh Balhara, Ashwani Mishra, Hem Sethi, Shalini Singh, and Sudhir Kumar Khandelwal. “Time Trends of Cannabis Use Among Treatment-Seeking Individuals at Government De-Addiction Centers Across India Over a Period of 7 Years.” Indian Journal of Psychological Medicine 38, no. 4 (2016): 331–35. https://doi.org/10.4103/0253-7176.185961.

25. Yatan Pal Singh Balhara, Shaul Lev-Ran, José Martínez-Raga, Amine Benyamina, Shalini Singh, Lisa Blecha, and Nestor Szerman. “State of Training, Clinical Services, and Research on Dual Disorders Across France, India, Israel, and Spain.” Journal of Dual Diagnosis 12, no. 3–4 (October 1, 2016): 252–60. https://doi.org/10.1080/15504263.2016.1254309.

26. Shalini Singh, and Yatan Pal Singh Balhara. “A Review of Indian Research on Co- Occurring Psychiatric Disorders and Alcohol Use Disorders.” Indian Journal of Psychological Medicine, Indian Journal of Psychological Medicine 38, 38, no. 1, 1 (February 2016): 10, 10–19. https://doi.org/10.4103/0253-7176.175089, 10.4103/0253- 7176.175089.

27. Shalini Singh, SK Sinha, R Saha, Mukesh Jha, and DK Kataria. "Knowledge, attitude and practice related to tobacco use and cessation among young medical professionals." Indian Journal of Social Psychiatry 30, no. 1-2 (2014): 35-42.

28. Mina, Shaily, Masarat Jabeen, Shalini Singh, and Rohit Verma. “Gender Differences in Depression and Anxiety Among Atopic Dermatitis Patients.” Indian Journal of Dermatology 60, no. 2 (2015): 211. https://doi.org/10.4103/0019-5154.152564.

29. Budania, Satish Kumar, Monika Rathi, Shalini Singh, and Suresh Yadav. “Serum Cholesterol and Depression: A Puzzle Never Finished.” Journal of the Scientific Society 42, no. 2 (May 1, 2015): 59. https://doi.org/10.4103/0974-5009.157023.

30. Shruti, Aggarwal, Shalini Singh, and Dinesh Kataria. “Knowledge, Attitude and Social Distance Practices of Young Undergraduates towards Mental Illness in India: A Comparative Analysis.” Asian Journal of Psychiatry 23 (October 1, 2016): 64–69. https://doi.org/10.1016/j.ajp.2016.07.012.

31. Tarun Yadav & Shalini Singh. “Transient lesion in the splenium of corpus callosum in a case of acute psychosis with catatonia: pathophysiological hypothesis and literature review. RANZCP Abstracts.” Australian & New Zealand Journal of Psychiatry 47, no. 1_suppl (May 1, 2013): 1–98. https://doi.org/10.1177/0004867412486854.”. Australian & New Zealand Journal of Psychiatry 47 (May 2013): 1-98. 9.

32. Shalini Singh, Shruti Aggarwal, Suman Kumar Sinha, and Dinesh Kataria. "How are you feeing today doctor? Mental wellbeing of young medical professionals: A cross- sectional analysis. Free papers (posters).” Indian Journal of Psychiatry 56, no. Suppl 1 (January 2014): S63–96. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943346/. 

33. Buttar, Navtej S., Cathrine J. DeMars, Gwen Lomberk, Sumera Rizvi, Juliana Bonilla-Velez, Shalini Achra, Shahrooz Rashtak, Kenneth K. Wang, Martin E. Fernandez- Zapico, and Raul Urrutia. “Distinct Role of Kruppel-like Factor 11 in the Regulation of Prostaglandin E2 Biosynthesis.” The Journal of Biological Chemistry 285, no. 15 (April 9, 2010): 11433–44. https://doi.org/10.1074/jbc.M109.077065.

Book chapters:  

34. Shalini Singh. (2022) Women and Mental Health. In: Chadda RK et al (eds.) Mental Health at Crossroads, challenges and solutions. Chandigarh: White falcon Publishing. 139-145.

35. Shalini Singh. (2022) Women and Mental Health. In: Chadda RK et al (eds.) Mental Health at Crossroads, challenges and solutions. Chandigarh: White falcon Publishing. 139-145.

36. Rakesh Lal, and Shalini Singh. “Assessment Tools for Screening and Clinical Evaluation of Psychosocial Aspects in Addictive Disorders.” Indian Journal of Psychiatry 60, no. 8 (January 1, 2018): 444. https://doi.org/10.4103/psychiatry. Indian Journal of Psychiatry_12_18.

37. Dhawan A, Singh Shalini. Social Dimensions of Substance Use Disorders. In: RK Chadda, Vinay Kumar, Nitin Gupta, SiddharthSarkar (eds) Social Psychiatry: Principles and Clinical Perspective, New Delhi: Published by Jaypee Brothers; 2018: 217-226.

38. Yatan Pal Singh Balhara & Shalini Singh. “The relationship between schizophrenia, anti-psychotics and dysglycemia.” In "RSSDI-Annual Conference Update 2015". Chapter91: 438-445.

39. Yatan Pal Singh Balhara & Shalini Singh. ““Psychosociology of diabetes mellitus” In ‘RSSDI-Textbook of Diabetes Mellitus’.Chapter 42: 312-325.

Books/monographs/project reports/ proceedings from workshops (non-peer reviewed publications)

40. Review of the national policies on narcotic drugs and psychotropic substances across the South East Asia region.  Principle Investigator- Yatan Pal Singh Balhara. Duration- 2 months (June- July 2018). Funding Agency- World Health Organisation- South East Asia Regional Office. WHO- SEARO publication

41. Balhara YPS, Singh S. (2018). Recommendations on identification and management of behavioral addictions. Report submitted to WHO SEARO for publication.

42. Shalini Singh, YPS Balhara. “What makes patients with co-occurring psychiatric and substance use disorder complete in-patient treatment: Findings from a tertiary care treatment centre in India” presented at the First National Conference on Addiction Psychiatry – 2017, New Delhi.

43. Balhara YPS, Singh S, Indrakamhaeng D. A situation analysis of the status of policy plans and Programme for addressing depressive disorders among persons with physical Non-Communicable Diseases (NCDs) and substance use disorders across the WHO South East Asian Region (SEAR). WHO SEARO publication.

44. YPS Balhara, Shalini Singh, Arpit Parmar, Ratika Sharma (2016). “To assess burden and socio-economic cost associated with alcohol use among individuals seeking treatment at a substance use disorder treatment centre.” WHO SEARO publication

45. YPS Balhara, Shalini Singh. (2016).  “Review of secondary and tertiary prevention strategies for prevention of illicit substance use disorders. WHO SEARO publication

46. YPS Balhara, Shalini Singh. (2016).  “Review of primary prevention strategies for prevention of illicit substance use disorders. WHO SEARO publication

9. Presentations made at scientific meetings/ conferences/ workshops

10. Investigator/ Co-investigator in funded projects along with year completed/ongoing

As principal investigator:

As co-investigator

1. Investigator/Co-investigator in non-funded projects along with year and title completed/ongoing

12. Thesis supervised for MD/ DM/PhD

- as guide 1  

-as co-guide 5

13. Awards and Honours

1. Selected as Associate Fellow of the National Academy of Medical Sciences in September, 2022

2. Awarded 1-year trainee fellowship of American Academy of Addiction Psychiatry (member no. 2582) from January- December 2018.

3. Winner, Post-graduate debate at the National Conference of Addictio Psychiatry in 2017

4. Awarded the American Association of Addiction Psychiatry (AAAP) 2017 International Trainee Travel Scholarship

5. Travel award by the Indian Council of Medical Research under the International Travel Support for young scientist scheme in the year 2017

6. Awarded fellowship of ‘Course for Academic Development of Psychiatrists’ by the Japanese Young Psychiatrist Organization in Japan, February 2016.

7. Travel award by Science & Engineering Research Board (SERB), Government of India under the International Travel Support Scheme for young scientist - 2015

8. Best Presenter award at the National P.G. Development Program - 2012, Indian Psychiatric Society

14. Any other relevant information

• Book co-editor : Guidelines for Assessment and Treatment of Substance Use Disorders: A Handbook for IRCAs.

• Instructor in online training for clinical staff (Doctors, Counsellors and Nurses) of Ministry of Social Justice and Empowerment (MoSJE) supported IRCAs and ODICs: as part of funded project by the Ministry of Social Justice and Empowerment.

• Invited talk in lecture series: Can a neighbourhood fall sick? Opioid addiction, collective violence, and currents of death in contemporary India. Organised by CSDS (Centre for Study of Developing Societies, India) in January 2021.

• Organising committee member of the first national conference of the Addiction Psychiatry Society of India (APSI) held in January 2021

• Instructor in Capacity Building Training program on Standard Treatment Guideline for the Management of Substance Use Disorder, Government of Odisha. Training program held in January, 2021

• Co-ordinator and resource person for Programme on Orientation of Psychiatrists (Resource Persons) on Management of SUD, Ministry of Health and Family Welfare, October 2020

• Resource person for Wellness symposia for Undergraduate and postgraduate students: “MATE (Mind Activation Through Education)” AIIMS, AIIMS Student Wellness Program, throughout later half of 2020

• Invited lecture in Project LEAD: training program for medical professionals on ‘Alcohol related Liver Diseases’, Institute of Liver and Biliary Sciences, September 2020

• Co-contributor on report and advisory document on Need of reforms in the Drug Policies of India: Decriminalization of personal consumption of drugs for the Ministry of Health and Family Welfare in collaboration with Narcotics Control Bureau (NCB), Ministry of Home Affairs, Government of India. Specific component: “International perspective and study of prevalent model in other countries and appropriate reforms in our laws for reform and rehabilitation of drug addicts”. November 2020.

• Development of public service announcement and resource material for general public regarding tobacco and alcohol use during lockdown period in 2020 for the Ministry of Health and Family Welfare website. April, 2020

• Peer reviewer for following journals:

  • Frontier’s sociology

  • International Journal of Mental Health and Addiction

  • Indian Journal of Social Psychiatry